Dividend
-
-
-
-
-
-
-
Matinas BioPharma Reports Second Quarter 2021 Financial Results and Operational Highlights
-
-
-
-
-
-
-
Matinas BioPharma Reports Third Quarter 2019 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Matinas BioPharma (MTNB) Prices $8M Public Offering
-
-
-
-
-
-
436,668 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

